fromMedCity News1 month agoPrivacy professionalsOuster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions - MedCity NewsPeter Marks' departure from the FDA raises concerns over regulatory support for novel therapies, especially in biologics.
fromNew York Post3 days agoCancerFDA names oncologist Vinay Prasad as top vaccine officialVinay Prasad appointed as director of FDA's Center for Biologics Evaluation and Research.
fromMedCity News1 month agoPrivacy professionalsOuster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions - MedCity NewsPeter Marks' departure from the FDA raises concerns over regulatory support for novel therapies, especially in biologics.
fromNew York Post3 days agoCancerFDA names oncologist Vinay Prasad as top vaccine officialVinay Prasad appointed as director of FDA's Center for Biologics Evaluation and Research.